Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations.
Nikola CurikAdam LaznickaVaclava PolivkovaJitka KrizkovaEva PokornaPavel SemerakPavla SuchankovaPavel BurdaAndreas HochhausKaterina Machova PolakovaPublished in: Leukemia (2024)